A type of drug already used to treat obesity and Type 2 diabetes, when taken six months prior to the diagnosis of COVID-19, was associated with a decreased risk of hospitalization, respiratory complications and death in COVID-19 ...
Sep 27, 2021
0
139
Researchers at CDDEP, University of California, Berkeley, and the Government of Tamil Nadu recently published 'SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, South India: a prospective, active ...
Aug 16, 2021
0
233
Neurodegenerative disorders that cause dementia increase the risk of contracting severe COVID-19 and dying from the disease. For people with Alzheimer's the risk is three times greater. It can be six times greater if they ...
Jun 3, 2021
0
3
One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The ...
Apr 7, 2021
0
30
(HealthDay)—A new study adds to mounting evidence that COVID patients have an added risk of stroke.
Mar 19, 2021
0
7
An article published Jan. 5 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association cites decades of published scientific evidence to make a compelling case for SARS-CoV-2's expected long-term effects on the ...
Jan 5, 2021
0
96
Women with post-traumatic stress disorder (PTSD) and depression have an almost fourfold greater risk of early death from cardiovascular disease, respiratory disease, type 2 diabetes, accidents, suicide, and other causes than ...
Dec 4, 2020
0
80
Results from a new Cleveland Clinic-led study suggest that melatonin, a hormone that regulates the sleep-wake cycle and is commonly used as an over-the-counter sleep aid, may be a viable treatment option for COVID-19.
Nov 9, 2020
0
6474
(HealthDay)—When adults with Down syndrome contract COVID-19, their risk of dying is much higher than the norm, a large, new study finds.
Oct 27, 2020
0
7
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.
Oct 20, 2020
0
1
